RegSmart Life Science AB

SGS Fimko Ltd.

ProPharma

Standardisation in automation

, reduced operating costs. And it worked. With support from Festo.

Novo Nordisk tells staff to return to office

At the turn of the year, Novo Nordisk employees will no longer be able to work remotely. According to the company’s new CEO, the move is intended to accelerate ...

Truly Labs AB

Läkemedel mot kronisk bihåleinflammation får grönt ljus

Astra Zenecas läkemedel Tezspire har fått ett positivt utlåtande från det europeiska läkemedelsverket EMA, för behandling av kronisk rinosinuit med näspolyper.

Fast Optical Sectioning of Developing Organisms and Tissue Microstructures

ZEISS Lattice SIM 3 exploits the full potential of the SIM Apotome technology.

Optimize Courier SUPPLIERS (DISTRIBUTORS)

Roche’s Genentech terminates licencing deal with Norwegian biotech

Genentech is ending a license collaboration with Norwegian biotech Nykode Therapeutics regarding a clinical stage cancer vaccine program.

AZ gets approval for drug targeting rare disease – it may reduce cortisone dependence

AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.

Lonza

Joy at Egetis after positive CHMP opinion – ”The single most important milestone”

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."

ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions

ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS 2025 in Copenhagen.

Webinar: Support Trial Patients Transitioning to the Commercial Space

Register for expert insights on supporting Phase III clinical trial patients post-approval and read our blog on advanced Patient Assistance Programs.

Roche breddar användningen av sitt tidigare cancerläkemedel

Roche har fått FDA-godkännande för att använda sitt läkemedel Gazyva vid behandling av vuxna med aktiv lupusnefrit – en allvarlig njurkomplikation vid SLE. Besk...

A mass flow controller that is silent, fast and cost-effective

Portable ventilator breathing devices, bioreactors or the dosing of inert gases all rely on the highest control dynamics. That is exactly what the proportional ...

Ukraine war fuels rise of totally resistent bacteria

War-torn Ukraine is not just suffering from hostile attacks from a foreign aggressor, but also from the threat of a totally resistant and contagious bacteria.

Wusson Accelerator AB

Ylva Trolle Lagerros: ”Vissa borde få läkemedel mot obesitas subventionerat”

Som ledande expert på obesitas har Ylva Trolle Lagerros synts mycket i media på sista tiden. I en intervju med Life Science Sweden talar hon om stigmat kring fe...

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

Nytt läkemedel ska förenkla behandling av blödarsjuka

En ny typ av behandling mot hemofili, som bara behöver ges varannan månad, har godkänts av den amerikanska läkemedelsmyndigheten FDA.

ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin

More than 50 distinguished speakers from leading manufacturing companies.

“Research is always a lot of failures and a few successes”

Gene therapies open up fantastic possibilities, but they are also extremely expensive to produce. Genenova aims to change that and make the treatments accessibl...